Literature DB >> 28462211

Oxidative and nitrosative stress during pulmonary ischemia-reperfusion injury: from the lab to the OR.

Jan F Gielis1,2, Paul A J Beckers1, Jacco J Briedé3, Paul Cos2, Paul E Van Schil1.   

Abstract

Oxidative and nitrosative stress are an umbrella term for pathophysiological processes that involve free radical generation during inflammation. In this review, the involvement of reactive oxygen and nitrogen species is evaluated during lung ischemia-reperfusion injury (LIRI) from a surgical point of view. The main biochemical and cellular mechanisms behind free radical generation are discussed, together with surgical procedures that may cause reperfusion injury. Finally, different therapeutic strategies are further explored. A literature search was performed, searching for "lung ischemia reperfusion injury", "reperfusion injury", "large animal model" and different search terms for each section: "surgery", "treatment", "cellular mechanism", or "enzyme". Although reperfusion injury is not an uncommon entity and there is a lot of evidence concerning myocardial ischemia-reperfusion injury, in the lung this phenomenon is less extensively described and studies in large animals are not easy to come by. With increasing number of patients on waiting lists for lung transplant, awareness for this entity should all but rise.

Entities:  

Keywords:  Ischemia reperfusion injury; nitrosative stress; oxidative stress; reactive nitrogen species (RNS); reactive oxygen species (ROS)

Year:  2017        PMID: 28462211      PMCID: PMC5395487          DOI: 10.21037/atm.2017.03.32

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  95 in total

1.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

Authors:  Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill
Journal:  J Heart Lung Transplant       Date:  2005-06-04       Impact factor: 10.247

2.  Long-term survival of a phase I clinical trial of isolated lung perfusion with melphalan for resectable lung metastases.

Authors:  Willem A Den Hengst; Bart P Van Putte; Jeroen M H Hendriks; Bernard Stockman; Wim-Jan P van Boven; Joost Weyler; Franz M N H Schramel; Paul E Y Van Schil
Journal:  Eur J Cardiothorac Surg       Date:  2010-05-15       Impact factor: 4.191

3.  Ischemic preconditioning enhances donor lung preservation in the rabbit.

Authors:  R I Gasparri; N C Jannis; W J Flameng; T E Lerut; D E Van Raemdonck
Journal:  Eur J Cardiothorac Surg       Date:  1999-12       Impact factor: 4.191

Review 4.  Bronchial blood supply after lung transplantation without bronchial artery revascularization.

Authors:  Mark R Nicolls; Martin R Zamora
Journal:  Curr Opin Organ Transplant       Date:  2010-10       Impact factor: 2.640

5.  Influence of graft ischemic time on outcomes following lung transplantation.

Authors:  S M Fiser; I L Kron; S M Long; A K Kaza; J A Kern; D C Cassada; D R Jones; M C Robbins; C G Tribble
Journal:  J Heart Lung Transplant       Date:  2001-12       Impact factor: 10.247

6.  Argon and xenon ventilation during prolonged ex vivo lung perfusion.

Authors:  An Martens; Matteo Montoli; Giulio Faggi; Ira Katz; Jan Pype; Bart M Vanaudenaerde; Dirk E M Van Raemdonck; Arne P Neyrinck
Journal:  J Surg Res       Date:  2015-10-12       Impact factor: 2.192

7.  Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury.

Authors:  J M Dodd-O; D B Pearse
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

8.  Anoxia-reoxygenation versus ischemia in isolated rat lungs.

Authors:  G Zhao; A B al-Mehdi; A B Fisher
Journal:  Am J Physiol       Date:  1997-12

9.  Continuous infusion of nitroglycerin improves pulmonary graft function of non-heart-beating donor lungs.

Authors:  Florian Loehe; Gerhard Preissler; Thorsten Annecke; Iris Bittmann; Karl W Jauch; Konrad Messmer
Journal:  Transplantation       Date:  2004-06-27       Impact factor: 4.939

10.  N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation.

Authors:  Ilhan Inci; Wei Zhai; Stephan Arni; Sven Hillinger; Peter Vogt; Walter Weder
Journal:  Ann Thorac Surg       Date:  2007-07       Impact factor: 4.330

View more
  5 in total

1.  Troxerutin attenuates oxygen‑glucose deprivation and reoxygenation‑induced oxidative stress and inflammation by enhancing the PI3K/AKT/HIF‑1α signaling pathway in H9C2 cardiomyocytes.

Authors:  Zhang-Ping Yu; Han-Qiao Yu; Jun Li; Chao Li; Xian Hua; Xiao-Sheng Sheng
Journal:  Mol Med Rep       Date:  2020-06-03       Impact factor: 2.952

2.  The Nox1/Nox4 inhibitor attenuates acute lung injury induced by ischemia-reperfusion in mice.

Authors:  Yu Cui; Yu Wang; Gen Li; Wan Ma; Xiao-Shuang Zhou; Jia Wang; Bin Liu
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

3.  Schizandrin B attenuates hypoxia/reoxygenation injury in H9c2 cells by activating the AMPK/Nrf2 signaling pathway.

Authors:  Bo Zhao; Guang-Ping Li; Jian-Jun Peng; Li-Hui Ren; Li-Cheng Lei; Hui-Ming Ye; Zuo-Yan Wang; Sheng Zhao
Journal:  Exp Ther Med       Date:  2021-01-18       Impact factor: 2.447

Review 4.  Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review.

Authors:  Tara Talaie; Laura DiChiacchio; Nikhil K Prasad; Chetan Pasrija; Walker Julliard; David J Kaczorowski; Yunge Zhao; Christine L Lau
Journal:  Transplant Direct       Date:  2021-01-07

5.  CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro.

Authors:  Yun Ding; Pengjie Tu; Yiyong Chen; Yangyun Huang; Xiaojie Pan; Wenshu Chen
Journal:  Respir Res       Date:  2021-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.